All Daavlin’s team members are important. Bob Golding has a special role here that is vital to our company.
He is our Director of Research and Development. He keeps up on emerging technology and how it helps Daavlin have a positive impact on treatment.
Only 29 days from today is the start of the AAD Conference! Is “Alternatives for Psoriasis Treatment in a World of Biologics #F010” on your agenda? Bob will be available at the Daavlin exhibit booth to discuss the safety and efficacy of phototherapy as compared to biologics. Join him with your questions and comments. Booth #937